A Pieter Kappetein

Author PubWeight™ 116.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009 17.17
2 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014 9.73
3 Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013 4.34
4 Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg 2005 2.80
5 Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med 2011 2.65
6 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 2012 2.44
7 Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 2013 2.41
8 Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010 2.40
9 Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol 2010 2.24
10 Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system--a Bern-Rotterdam Study. Am Heart J 2010 1.87
11 Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol 2012 1.80
12 Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. Eur J Cardiothorac Surg 2011 1.77
13 Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization. J Am Coll Cardiol 2013 1.76
14 Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial. Catheter Cardiovasc Interv 2011 1.71
15 2014 ESC/EACTS guidelines on myocardial revascularization. Rev Esp Cardiol (Engl Ed) 2015 1.69
16 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Ann Thorac Surg 2012 1.59
17 The new EuroSCORE II does not improve prediction of mortality in high-risk patients undergoing cardiac surgery: a collaborative analysis of two European centres. Eur J Cardiothorac Surg 2013 1.55
18 Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer. Ann Thorac Surg 2005 1.54
19 Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg 2005 1.54
20 Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons. Circ Cardiovasc Qual Outcomes 2012 1.50
21 Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement. EuroIntervention 2008 1.47
22 Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease. JACC Cardiovasc Interv 2013 1.42
23 The European Association for Cardio-Thoracic Surgery (EACTS) database: an introduction. Eur J Cardiothorac Surg 2013 1.42
24 Do we need separate risk stratification models for hospital mortality after heart valve surgery? Ann Thorac Surg 2008 1.41
25 Impact of methodology and assumptions in a cost-effectiveness analysis on transcatheter aortic valve replacement. J Thorac Cardiovasc Surg 2013 1.38
26 Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur Heart J 2012 1.29
27 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Thorac Cardiovasc Surg 2012 1.28
28 Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg 2009 1.22
29 Preoperative and operative predictors of delirium after cardiac surgery in elderly patients. Eur J Cardiothorac Surg 2012 1.22
30 Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature. J Am Coll Cardiol 2013 1.11
31 The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 2006 1.10
32 2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention 2015 1.08
33 EACTS guidelines for the use of patient safety checklists. Eur J Cardiothorac Surg 2012 1.07
34 Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. J Thorac Cardiovasc Surg 2011 1.07
35 A systematic review of risk prediction in adult cardiac surgery: considerations for future model development. Eur J Cardiothorac Surg 2013 1.06
36 Factors associated with perioperative complications and long-term results after pulmonary resection for primary carcinoma of the lung. Eur J Cardiothorac Surg 2003 1.05
37 Current concepts on coronary revascularization in diabetic patients. Eur Heart J 2011 1.05
38 Guideline for the surgical treatment of atrial fibrillation. Eur J Cardiothorac Surg 2013 1.03
39 Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode. J Thorac Cardiovasc Surg 2006 0.98
40 Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome. Ann Thorac Surg 2011 0.98
41 Surgery in current therapy for infective endocarditis. Vasc Health Risk Manag 2011 0.97
42 Predicting prognosis in cardiac surgery: a prophecy? Eur J Cardiothorac Surg 2012 0.96
43 What the cardiothoracic surgeon wants to know from the radiologist: from X-ray reporting to imaging consultancy and Heart Team membership. Pediatr Radiol 2015 0.95
44 Lung resection for non-small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population. Ann Thorac Surg 2003 0.95
45 The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. Eur Heart J 2013 0.94
46 Cost-effectiveness of transcatheter valvular interventions: economic challenges. EuroIntervention 2013 0.94
47 Transcatheter aortic valve implantation: 10-year anniversary part II: clinical implications. Eur Heart J 2012 0.93
48 Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters. Ann Thorac Surg 2005 0.93
49 Non-inferiority study design: lessons to be learned from cardiovascular trials. Eur Heart J 2012 0.93
50 The SYNTAX score and its clinical implications. Heart 2013 0.92
51 Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study. Eur J Cardiothorac Surg 2007 0.91
52 Costs for surgical aortic valve replacement according to preoperative risk categories. Ann Thorac Surg 2013 0.87
53 The 4th European Association for Cardio-Thoracic Surgery adult cardiac surgery database report. Interact Cardiovasc Thorac Surg 2011 0.86
54 Long-term follow-up and quality of life after closure of ventricular septal defect in adults. Eur J Cardiothorac Surg 2007 0.86
55 Surgical treatment of active native aortic valve endocarditis with allografts and mechanical prostheses. Ann Thorac Surg 2009 0.86
56 Coronary artery bypass grafting: Part 1--the evolution over the first 50 years. Eur Heart J 2013 0.85
57 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Catheter Cardiovasc Interv 2012 0.85
58 The role of EuroSCORE II in 21st century cardiac surgery practice. Eur J Cardiothorac Surg 2012 0.84
59 The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis. EuroIntervention 2012 0.83
60 [2014 ESC/EACTS Guidelines on myocardial revascularization]. Kardiol Pol 2014 0.83
61 Cost effectiveness of coronary revascularisation. EuroIntervention 2010 0.81
62 A crucial factor in shared decision making: the team approach. Lancet 2011 0.81
63 Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients. Ann Thorac Surg 2012 0.81
64 Appropriate coronary artery bypass grafting use in the percutaneous coronary intervention era: are we finally making progress? Semin Thorac Cardiovasc Surg 2012 0.81
65 Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. JACC Cardiovasc Interv 2012 0.81
66 Usefulness of microsimulation to translate valve performance into patient outcome: patient prognosis after aortic valve replacement with the Carpentier-Edwards supra-annular valve. J Thorac Cardiovasc Surg 2007 0.80
67 Transcatheter aortic valve implantation after PARTNER: what is up next? EuroIntervention 2010 0.79
68 How to assess risks of valve surgery: quality, implementation and future of risk models. Heart 2009 0.79
69 Complexity of coronary vasculature predicts outcome of surgery for left main disease. Ann Thorac Surg 2009 0.77
70 Subgroup analyses in trial reports comparing percutaneous coronary intervention with coronary artery bypass surgery. JAMA 2013 0.77
71 Drug-eluting stent implantation for coronary artery disease: current stents and a comparison with bypass surgery. Curr Opin Pharmacol 2012 0.76
72 Virtual reality 3D echocardiography in the assessment of tricuspid valve function after surgical closure of ventricular septal defect. Cardiovasc Ultrasound 2007 0.75
73 Surgical implications of coronary arterial anatomy in adults with congenital cardiac disease. Open Cardiovasc Med J 2008 0.75
74 Surgical or transcatheter mitral valve intervention: complex disease requires complex decisions. EuroIntervention 2014 0.75
75 Long-term survival of young patients with coronary artery disease is best realized through surgical revascularization with mammary arteries. J Am Coll Cardiol 2013 0.75
76 Invited commentary. Ann Thorac Surg 2012 0.75
77 Single-centre experience with mitral valve repair in asymptomatic patients with severe mitral valve regurgitation. Interact Cardiovasc Thorac Surg 2013 0.75
78 Carriage of reduced-function CYP2C19 allele among patients treated with clopidogrel. JAMA 2011 0.75
79 Nonrandomized data on drug-eluting stents compared with coronary bypass surgery caution with interpretation. J Am Coll Cardiol 2011 0.75
80 Off-pump or on-pump coronary-artery bypass grafting. N Engl J Med 2012 0.75
81 Details in a meta-analysis comparing mitral valve repair to replacement for ischemic regurgitation. Eur J Cardiothorac Surg 2012 0.75
82 Outcome after aortic valve replacement in young adults: is patient profile more important than prosthesis type? J Heart Valve Dis 2006 0.75
83 Hierarchical testing of composite endpoints: applying the win ratio to percutaneous coronary intervention versus coronary artery bypass grafting in the SYNTAX trial. EuroIntervention 2017 0.75
84 Towards excellence in revascularization for left main coronary artery disease. Curr Opin Cardiol 2012 0.75
85 Arterial grafting and complete revascularization: challenge or compromise? Curr Opin Cardiol 2013 0.75
86 Multivessel coronary artery disease: quantifying how recent trials should influence clinical practice. Expert Rev Cardiovasc Ther 2013 0.75
87 Coronary artery bypass grafting: the past, present, and the future. Eur Heart J 2013 0.75
88 Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS). EuroIntervention 2011 0.75
89 Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgery. EuroIntervention 2005 0.75
90 A meta-analysis on clinical outcomes after transaortic transcatheter aortic valve implantation by the Heart Team. EuroIntervention 2017 0.75
91 The bright future of cardiothoracic and vascular surgery: the role of EACTS. Eur J Cardiothorac Surg 2013 0.75
92 Intraoperative real time three-dimensional transesophageal echocardiographic measurement of hemodynamic, anatomic and functional changes after aortic valve replacement. Echocardiography 2008 0.75
93 Tools and Techniques--Clinical: the transaortic approach through a mini-sternotomy using the self-expandable CoreValve Revalving System. EuroIntervention 2013 0.75
94 VARC endpoint definition compliance rates in contemporary transcatheter aortic valve implantation studies. EuroIntervention 2016 0.75
95 Acute dehiscence of a valve prosthesis 5 years after implantation. Int J Cardiol 2007 0.75
96 Management of elderly patients with aortic valve disease. Nat Clin Pract Cardiovasc Med 2008 0.75
97 Failing surgical bioprosthesis in aortic and mitral position. EuroIntervention 2013 0.75
98 Emergency surgery due to haematoma in a case of left atrial myxoma. Heart Lung Circ 2006 0.75